Results
1
Companies which can be considered undervalued when accounting for expected future growth (PEG under 0.8)
1 companies
GlaxoSmithKline Pakistan
Market Cap: PK₨101.6b
Operates as a biopharma company in Pakistan.
GLAXO
PK₨318.92
7D
-5.3%
1Y
-18.1%